[ Back to EurekAlert! ]

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine

High-Risk Blockages

Caption: Plaques due to atherosclerosis in darapladib-treated vessels (bottom) are less severe and complex as compared to non-darapladib-treated control groups.

Credit: Robert L. Wilensky, M.D., University of Pennsylvania School of Medicine; Nature Medicine

Usage Restrictions: None

Related news release: Inhibiting cholesterol-associated protein reduces high-risk blockages in arteries


[ Back to EurekAlert! ]